Literature DB >> 10548271

Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task.

F Ferrari1, A Ottani, R Vivoli, D Giuliani.   

Abstract

To ascertain whether the cannabinoid agonist HU 210 (25, 50, or 100 microg/kg, IP) influences rat spatial learning, water-maze performance was examined in the place (hidden platform)--and cue (visible platform)--versions of the Morris water maze. In addition, other unlearned behaviors were examined, namely, vocalization and wall hugging during the place task, and motor abilities during a motor test battery. The results obtained show that HU 210 at 50 or 100 microg/kg (once daily for 4 days, 60 min before a daily session) impaired learning in the place version but not in the cue one; wall hugging and enhanced vocalization were also displayed by the animals in the fourth session. Motor activity was compromised by the same treatment schedule. When the drug was discontinued, the effects produced by HU 210 at 50 microg/kg reversed in 3 days, while disruption of acquisition and vocalization caused by HU 210 at 100 microg/kg remained after 7 days' abstinence. Discussion centers on the possible specific cognitive mechanisms affected by the drug and on aspecific factors (i.e., anxiety-like state), which may contribute to the impairment of spatial learning.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548271     DOI: 10.1016/s0091-3057(99)00106-9

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.

Authors:  Mark D Black; Rachel J Stevens; Nancy Rogacki; Robert E Featherstone; Yaw Senyah; Odessa Giardino; Beth Borowsky; Jeanne Stemmelin; Caroline Cohen; Philippe Pichat; Michal Arad; Segev Barak; Amaya De Levie; Ina Weiner; Guy Griebel; Geoffrey B Varty
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

2.  The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.

Authors:  Fabrício A Pamplona; Rui D S Prediger; Pablo Pandolfo; Reinaldo N Takahashi
Journal:  Psychopharmacology (Berl)       Date:  2006-09-01       Impact factor: 4.530

3.  Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice.

Authors:  S A Varvel; E A Anum; A H Lichtman
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

4.  Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists.

Authors:  Matthew N Hill; Larissa M Froese; Anna C Morrish; Jane C Sun; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

5.  Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats.

Authors:  R E Hampson; S A Deadwyler
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Pharmacological elevation of anandamide impairs short-term memory by altering the neurophysiology in the hippocampus.

Authors:  Anushka V Goonawardena; John Sesay; Cheryl Ann Sexton; Gernot Riedel; Robert E Hampson
Journal:  Neuropharmacology       Date:  2011-07-13       Impact factor: 5.250

Review 7.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

8.  Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure.

Authors:  Anushka V Goonawardena; Lianne Robinson; Gernot Riedel; Robert E Hampson
Journal:  Hippocampus       Date:  2010-09       Impact factor: 3.899

9.  Pharmacological effects of cannabinoids on the reference and working memory functions in mice.

Authors:  Avdesh Avdesh; Yikai Hoe; Ralph N Martins; Mathew T Martin-Iverson
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

10.  Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.

Authors:  Laura E Wise; Andrew J Thorpe; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.